世界の軟骨無発生症（ACG）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Achondrogenesis Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0012
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、軟骨無発生症（ACG）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アコンドロジェネシスタイプIA、アコンドロジェネシスタイプIB、アコンドロジェネシスタイプII）、用途別市場規模（病院・クリニック、診断センター、研究所・学術機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・軟骨無発生症（ACG）の市場動向
・企業の競争状況、市場シェア
・軟骨無発生症（ACG）の種類別市場規模（アコンドロジェネシスタイプIA、アコンドロジェネシスタイプIB、アコンドロジェネシスタイプII）
・軟骨無発生症（ACG）の用途別市場規模（病院・クリニック、診断センター、研究所・学術機関、その他）
・軟骨無発生症（ACG）の北米市場規模2016-2027（アメリカ、カナダ）
・軟骨無発生症（ACG）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・軟骨無発生症（ACG）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・軟骨無発生症（ACG）の中南米市場規模2016-2027（メキシコ、ブラジル）
・軟骨無発生症（ACG）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Cook、Thermo Fisher Scientific、CooperSurgical、Illumina、Siemens、FUJIFILM Holdings、Koninklijke、Philips、Stryker、Toshiba Corporation、Invivoscribe、Abbott Molecular、INVITROGEN CORPORATION、Roche Molecular Systems）
・結論

Achondrogenesis is a number of disorders that are the most severe form of congenital chondrodysplasia (malformation of bones and cartilage). These conditions are characterized by a small body, short limbs, and other skeletal abnormalities.

Market Analysis and Insights: Global Achondrogenesis Market
The global Achondrogenesis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Achondrogenesis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Achondrogenesis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Achondrogenesis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Achondrogenesis market.

Global Achondrogenesis Scope and Market Size
Achondrogenesis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Achondrogenesis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Achondrogenesis type IA
Achondrogenesis type IB
Achondrogenesis type II

Segment by Application
Hospital & Clinics
Diagnostic centers
Research & Academic Institutes
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Cook
Thermo Fisher Scientific
CooperSurgical
Illumina
Siemens
FUJIFILM Holdings
Koninklijke
Philips
Stryker
Illumina
Siemens
Abbott Molecular

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Achondrogenesis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Achondrogenesis type IA
1.2.3 Achondrogenesis type IB
1.2.4 Achondrogenesis type II
1.3 Market by Application
1.3.1 Global Achondrogenesis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinics
1.3.3 Diagnostic centers
1.3.4 Research & Academic Institutes
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Achondrogenesis Market Perspective (2016-2027)
2.2 Achondrogenesis Growth Trends by Regions
2.2.1 Achondrogenesis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Achondrogenesis Historic Market Share by Regions (2016-2021)
2.2.3 Achondrogenesis Forecasted Market Size by Regions (2022-2027)
2.3 Achondrogenesis Industry Dynamic
2.3.1 Achondrogenesis Market Trends
2.3.2 Achondrogenesis Market Drivers
2.3.3 Achondrogenesis Market Challenges
2.3.4 Achondrogenesis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Achondrogenesis Players by Revenue
3.1.1 Global Top Achondrogenesis Players by Revenue (2016-2021)
3.1.2 Global Achondrogenesis Revenue Market Share by Players (2016-2021)
3.2 Global Achondrogenesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Achondrogenesis Revenue
3.4 Global Achondrogenesis Market Concentration Ratio
3.4.1 Global Achondrogenesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Achondrogenesis Revenue in 2020
3.5 Achondrogenesis Key Players Head office and Area Served
3.6 Key Players Achondrogenesis Product Solution and Service
3.7 Date of Enter into Achondrogenesis Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Achondrogenesis Breakdown Data by Type
4.1 Global Achondrogenesis Historic Market Size by Type (2016-2021)
4.2 Global Achondrogenesis Forecasted Market Size by Type (2022-2027)

5 Achondrogenesis Breakdown Data by Application
5.1 Global Achondrogenesis Historic Market Size by Application (2016-2021)
5.2 Global Achondrogenesis Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Achondrogenesis Market Size (2016-2027)
6.2 North America Achondrogenesis Market Size by Type
6.2.1 North America Achondrogenesis Market Size by Type (2016-2021)
6.2.2 North America Achondrogenesis Market Size by Type (2022-2027)
6.2.3 North America Achondrogenesis Market Size by Type (2016-2027)
6.3 North America Achondrogenesis Market Size by Application
6.3.1 North America Achondrogenesis Market Size by Application (2016-2021)
6.3.2 North America Achondrogenesis Market Size by Application (2022-2027)
6.3.3 North America Achondrogenesis Market Size by Application (2016-2027)
6.4 North America Achondrogenesis Market Size by Country
6.4.1 North America Achondrogenesis Market Size by Country (2016-2021)
6.4.2 North America Achondrogenesis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Achondrogenesis Market Size (2016-2027)
7.2 Europe Achondrogenesis Market Size by Type
7.2.1 Europe Achondrogenesis Market Size by Type (2016-2021)
7.2.2 Europe Achondrogenesis Market Size by Type (2022-2027)
7.2.3 Europe Achondrogenesis Market Size by Type (2016-2027)
7.3 Europe Achondrogenesis Market Size by Application
7.3.1 Europe Achondrogenesis Market Size by Application (2016-2021)
7.3.2 Europe Achondrogenesis Market Size by Application (2022-2027)
7.3.3 Europe Achondrogenesis Market Size by Application (2016-2027)
7.4 Europe Achondrogenesis Market Size by Country
7.4.1 Europe Achondrogenesis Market Size by Country (2016-2021)
7.4.2 Europe Achondrogenesis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Achondrogenesis Market Size (2016-2027)
8.2 Asia-Pacific Achondrogenesis Market Size by Type
8.2.1 Asia-Pacific Achondrogenesis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Achondrogenesis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Achondrogenesis Market Size by Type (2016-2027)
8.3 Asia-Pacific Achondrogenesis Market Size by Application
8.3.1 Asia-Pacific Achondrogenesis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Achondrogenesis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Achondrogenesis Market Size by Application (2016-2027)
8.4 Asia-Pacific Achondrogenesis Market Size by Region
8.4.1 Asia-Pacific Achondrogenesis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Achondrogenesis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Achondrogenesis Market Size (2016-2027)
9.2 Latin America Achondrogenesis Market Size by Type
9.2.1 Latin America Achondrogenesis Market Size by Type (2016-2021)
9.2.2 Latin America Achondrogenesis Market Size by Type (2022-2027)
9.2.3 Latin America Achondrogenesis Market Size by Type (2016-2027)
9.3 Latin America Achondrogenesis Market Size by Application
9.3.1 Latin America Achondrogenesis Market Size by Application (2016-2021)
9.3.2 Latin America Achondrogenesis Market Size by Application (2022-2027)
9.3.3 Latin America Achondrogenesis Market Size by Application (2016-2027)
9.4 Latin America Achondrogenesis Market Size by Country
9.4.1 Latin America Achondrogenesis Market Size by Country (2016-2021)
9.4.2 Latin America Achondrogenesis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Achondrogenesis Market Size (2016-2027)
10.2 Middle East & Africa Achondrogenesis Market Size by Type
10.2.1 Middle East & Africa Achondrogenesis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Achondrogenesis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Achondrogenesis Market Size by Type (2016-2027)
10.3 Middle East & Africa Achondrogenesis Market Size by Application
10.3.1 Middle East & Africa Achondrogenesis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Achondrogenesis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Achondrogenesis Market Size by Application (2016-2027)
10.4 Middle East & Africa Achondrogenesis Market Size by Country
10.4.1 Middle East & Africa Achondrogenesis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Achondrogenesis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Cook
11.1.1 Cook Company Details
11.1.2 Cook Business Overview
11.1.3 Cook Achondrogenesis Introduction
11.1.4 Cook Revenue in Achondrogenesis Business (2016-2021)
11.1.5 Cook Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Achondrogenesis Introduction
11.2.4 Thermo Fisher Scientific Revenue in Achondrogenesis Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 CooperSurgical
11.3.1 CooperSurgical Company Details
11.3.2 CooperSurgical Business Overview
11.3.3 CooperSurgical Achondrogenesis Introduction
11.3.4 CooperSurgical Revenue in Achondrogenesis Business (2016-2021)
11.3.5 CooperSurgical Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Achondrogenesis Introduction
11.4.4 Illumina Revenue in Achondrogenesis Business (2016-2021)
11.4.5 Illumina Recent Development
11.5 Siemens
11.5.1 Siemens Company Details
11.5.2 Siemens Business Overview
11.5.3 Siemens Achondrogenesis Introduction
11.5.4 Siemens Revenue in Achondrogenesis Business (2016-2021)
11.5.5 Siemens Recent Development
11.6 FUJIFILM Holdings
11.6.1 FUJIFILM Holdings Company Details
11.6.2 FUJIFILM Holdings Business Overview
11.6.3 FUJIFILM Holdings Achondrogenesis Introduction
11.6.4 FUJIFILM Holdings Revenue in Achondrogenesis Business (2016-2021)
11.6.5 FUJIFILM Holdings Recent Development
11.7 Koninklijke
11.7.1 Koninklijke Company Details
11.7.2 Koninklijke Business Overview
11.7.3 Koninklijke Achondrogenesis Introduction
11.7.4 Koninklijke Revenue in Achondrogenesis Business (2016-2021)
11.7.5 Koninklijke Recent Development
11.8 Philips
11.8.1 Philips Company Details
11.8.2 Philips Business Overview
11.8.3 Philips Achondrogenesis Introduction
11.8.4 Philips Revenue in Achondrogenesis Business (2016-2021)
11.8.5 Philips Recent Development
11.9 Stryker
11.9.1 Stryker Company Details
11.9.2 Stryker Business Overview
11.9.3 Stryker Achondrogenesis Introduction
11.9.4 Stryker Revenue in Achondrogenesis Business (2016-2021)
11.9.5 Stryker Recent Development
11.10 Toshiba Corporation
11.10.1 Toshiba Corporation Company Details
11.10.2 Toshiba Corporation Business Overview
11.10.3 Toshiba Corporation Achondrogenesis Introduction
11.10.4 Toshiba Corporation Revenue in Achondrogenesis Business (2016-2021)
11.10.5 Toshiba Corporation Recent Development
11.11 Invivoscribe
11.11.1 Invivoscribe Company Details
11.11.2 Invivoscribe Business Overview
11.11.3 Invivoscribe Achondrogenesis Introduction
11.11.4 Invivoscribe Revenue in Achondrogenesis Business (2016-2021)
11.11.5 Invivoscribe Recent Development
11.12 Abbott Molecular
11.12.1 Abbott Molecular Company Details
11.12.2 Abbott Molecular Business Overview
11.12.3 Abbott Molecular Achondrogenesis Introduction
11.12.4 Abbott Molecular Revenue in Achondrogenesis Business (2016-2021)
11.12.5 Abbott Molecular Recent Development
11.13 INVITROGEN CORPORATION
11.13.1 INVITROGEN CORPORATION Company Details
11.13.2 INVITROGEN CORPORATION Business Overview
11.13.3 INVITROGEN CORPORATION Achondrogenesis Introduction
11.13.4 INVITROGEN CORPORATION Revenue in Achondrogenesis Business (2016-2021)
11.13.5 INVITROGEN CORPORATION Recent Development
11.14 Roche Molecular Systems
11.14.1 Roche Molecular Systems Company Details
11.14.2 Roche Molecular Systems Business Overview
11.14.3 Roche Molecular Systems Achondrogenesis Introduction
11.14.4 Roche Molecular Systems Revenue in Achondrogenesis Business (2016-2021)
11.14.5 Roche Molecular Systems Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Achondrogenesis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Achondrogenesis type IA
Table 3. Key Players of Achondrogenesis type IB
Table 4. Key Players of Achondrogenesis type II
Table 5. Global Achondrogenesis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Achondrogenesis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Achondrogenesis Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Achondrogenesis Market Share by Regions (2016-2021)
Table 9. Global Achondrogenesis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Achondrogenesis Market Share by Regions (2022-2027)
Table 11. Achondrogenesis Market Trends
Table 12. Achondrogenesis Market Drivers
Table 13. Achondrogenesis Market Challenges
Table 14. Achondrogenesis Market Restraints
Table 15. Global Achondrogenesis Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Achondrogenesis Market Share by Players (2016-2021)
Table 17. Global Top Achondrogenesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Achondrogenesis as of 2020)
Table 18. Ranking of Global Top Achondrogenesis Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Achondrogenesis Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Achondrogenesis Product Solution and Service
Table 22. Date of Enter into Achondrogenesis Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Achondrogenesis Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Achondrogenesis Revenue Market Share by Type (2016-2021)
Table 26. Global Achondrogenesis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Achondrogenesis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Achondrogenesis Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Achondrogenesis Revenue Market Share by Application (2016-2021)
Table 30. Global Achondrogenesis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Achondrogenesis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Achondrogenesis Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Achondrogenesis Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Achondrogenesis Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Achondrogenesis Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Achondrogenesis Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Achondrogenesis Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Achondrogenesis Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Achondrogenesis Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Achondrogenesis Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Achondrogenesis Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Achondrogenesis Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Achondrogenesis Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Achondrogenesis Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Achondrogenesis Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Achondrogenesis Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Achondrogenesis Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Achondrogenesis Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Achondrogenesis Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Achondrogenesis Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Achondrogenesis Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Achondrogenesis Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Achondrogenesis Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Achondrogenesis Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Achondrogenesis Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Achondrogenesis Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Achondrogenesis Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Achondrogenesis Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Achondrogenesis Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Achondrogenesis Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Achondrogenesis Market Size by Country (2022-2027) & (US$ Million)
Table 62. Cook Company Details
Table 63. Cook Business Overview
Table 64. Cook Achondrogenesis Product
Table 65. Cook Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 66. Cook Recent Development
Table 67. Thermo Fisher Scientific Company Details
Table 68. Thermo Fisher Scientific Business Overview
Table 69. Thermo Fisher Scientific Achondrogenesis Product
Table 70. Thermo Fisher Scientific Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 71. Thermo Fisher Scientific Recent Development
Table 72. CooperSurgical Company Details
Table 73. CooperSurgical Business Overview
Table 74. CooperSurgical Achondrogenesis Product
Table 75. CooperSurgical Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 76. CooperSurgical Recent Development
Table 77. Illumina Company Details
Table 78. Illumina Business Overview
Table 79. Illumina Achondrogenesis Product
Table 80. Illumina Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 81. Illumina Recent Development
Table 82. Siemens Company Details
Table 83. Siemens Business Overview
Table 84. Siemens Achondrogenesis Product
Table 85. Siemens Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 86. Siemens Recent Development
Table 87. FUJIFILM Holdings Company Details
Table 88. FUJIFILM Holdings Business Overview
Table 89. FUJIFILM Holdings Achondrogenesis Product
Table 90. FUJIFILM Holdings Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 91. FUJIFILM Holdings Recent Development
Table 92. Koninklijke Company Details
Table 93. Koninklijke Business Overview
Table 94. Koninklijke Achondrogenesis Product
Table 95. Koninklijke Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 96. Koninklijke Recent Development
Table 97. Philips Company Details
Table 98. Philips Business Overview
Table 99. Philips Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 100. Philips Recent Development
Table 101. Stryker Company Details
Table 102. Stryker Business Overview
Table 103. Stryker Achondrogenesis Product
Table 104. Stryker Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 105. Stryker Recent Development
Table 106. Toshiba Corporation Company Details
Table 107. Toshiba Corporation Business Overview
Table 108. Toshiba Corporation Achondrogenesis Product
Table 109. Toshiba Corporation Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 110. Toshiba Corporation Recent Development
Table 111. Invivoscribe Company Details
Table 112. Invivoscribe Business Overview
Table 113. Invivoscribe Achondrogenesis Product
Table 114. Invivoscribe Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 115. Invivoscribe Recent Development
Table 116. Abbott Molecular Company Details
Table 117. Abbott Molecular Business Overview
Table 118. Abbott Molecular Achondrogenesis Product
Table 119. Abbott Molecular Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 120. Abbott Molecular Recent Development
Table 121. INVITROGEN CORPORATION Company Details
Table 122. INVITROGEN CORPORATION Business Overview
Table 123. INVITROGEN CORPORATION Achondrogenesis Product
Table 124. INVITROGEN CORPORATION Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 125. INVITROGEN CORPORATION Recent Development
Table 126. Roche Molecular Systems Company Details
Table 127. Roche Molecular Systems Business Overview
Table 128. Roche Molecular Systems Achondrogenesis Product
Table 129. Roche Molecular Systems Revenue in Achondrogenesis Business (2016-2021) & (US$ Million)
Table 130. Roche Molecular Systems Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Achondrogenesis Market Share by Type: 2020 VS 2027
Figure 2. Achondrogenesis type IA Features
Figure 3. Achondrogenesis type IB Features
Figure 4. Achondrogenesis type II Features
Figure 5. Global Achondrogenesis Market Share by Application: 2020 VS 2027
Figure 6. Hospital & Clinics Case Studies
Figure 7. Diagnostic centers Case Studies
Figure 8. Research & Academic Institutes Case Studies
Figure 9. Other Case Studies
Figure 10. Achondrogenesis Report Years Considered
Figure 11. Global Achondrogenesis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Achondrogenesis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Achondrogenesis Market Share by Regions: 2020 VS 2027
Figure 14. Global Achondrogenesis Market Share by Regions (2022-2027)
Figure 15. Global Achondrogenesis Market Share by Players in 2020
Figure 16. Global Top Achondrogenesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Achondrogenesis as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Achondrogenesis Revenue in 2020
Figure 18. Global Achondrogenesis Revenue Market Share by Type (2016-2021)
Figure 19. Global Achondrogenesis Revenue Market Share by Type (2022-2027)
Figure 20. North America Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Achondrogenesis Market Share by Type (2016-2027)
Figure 22. North America Achondrogenesis Market Share by Application (2016-2027)
Figure 23. North America Achondrogenesis Market Share by Country (2016-2027)
Figure 24. United States Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Achondrogenesis Market Share by Type (2016-2027)
Figure 28. Europe Achondrogenesis Market Share by Application (2016-2027)
Figure 29. Europe Achondrogenesis Market Share by Country (2016-2027)
Figure 30. Germany Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Achondrogenesis Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Achondrogenesis Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Achondrogenesis Market Share by Region (2016-2027)
Figure 40. China Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Achondrogenesis Market Share by Type (2016-2027)
Figure 48. Latin America Achondrogenesis Market Share by Application (2016-2027)
Figure 49. Latin America Achondrogenesis Market Share by Country (2016-2027)
Figure 50. Mexico Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Achondrogenesis Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Achondrogenesis Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Achondrogenesis Market Share by Country (2016-2027)
Figure 56. Turkey Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Achondrogenesis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Cook Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 61. CooperSurgical Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 62. Illumina Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 63. Siemens Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 64. FUJIFILM Holdings Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 65. Koninklijke Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 66. Philips Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 67. Stryker Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 68. Toshiba Corporation Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 69. Invivoscribe Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 70. Abbott Molecular Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 71. INVITROGEN CORPORATION Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 72. Roche Molecular Systems Revenue Growth Rate in Achondrogenesis Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

以下、関連資料のご紹介

世界の軟骨無発生症市場 2021：企業別、地域別、種類・用途別

Global Achondrogenesis Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z00275 2021年4月 107Pages
当調査資料では、軟骨無発生症のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。軟骨無発生症の種類別市場規模（アコンドロジェネシスタイプIA、アコンドロジェネシスタイプIB、アコンドロジェネシスタイプII）、用途別市場規模（病院・診療所、診断センター、研究...

世界のアデノシンデアミナーゼ欠損症（ADA）市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Market Size, Status and Forecast 2021-2027
QYR2104Z0094 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のインフィニバンド（InfiniBand）市場規模・現状・予測（2021年-2027年）

Global InfiniBand Market Size, Status and Forecast 2021-2027
QYR2104Z3157 2021年4月 98Pages
QYResearch社発行の本調査資料では、インフィニバンド（InfiniBand）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シングルデータレート、ダブルデータレート、クワッドデータレート、14データレート、拡張データレート）、用途別市場...

世界の癌胎児性抗原（CEA）市場規模・現状・予測（2021年-2027年）

Global Carcinoembryonic Antigen (CEA) Market Size, Status and Forecast 2021-2027
QYR2104Z1106 2021年4月 90Pages
QYResearch社発行の本調査資料では、癌胎児性抗原（CEA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CD66a、CD66b、CD66c、CD66d、CD66e、CD66f）、用途別市場規模（大腸がん、膵臓がん、卵巣がん、乳がん、甲...

世界のチャネルインアボックス（CiaB）市場規模・現状・予測（2021年-2027年）

Global Channel-in-a-Box Market Size, Status and Forecast 2021-2027
QYR2104Z1255 2021年4月 94Pages
QYResearch社発行の本調査資料では、チャネルインアボックス（CiaB）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ソフトウェア、ハードウェア）、用途別市場規模（住宅用、商業用、公共・政府インフラストラクチャ）、主要地域別市場規模（...

世界のエキシマレーザアニール装置（ELA）市場規模・現状・予測（2021年-2027年）

Global Excimer Laser Annealing (ELA) Market Size, Status and Forecast 2021-2027
QYR2104Z2268 2021年4月 94Pages
QYResearch社発行の本調査資料では、エキシマレーザアニール装置（ELA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（XeCl（308nm）ELA、KrF（248nm）ELA）、用途別市場規模（工業、実験室、その他）、主要地域別市場規...

世界の3D動脈スピンラベリング（3D ASL）市場規模・現状・予測（2021年-2027年）

Global 3D Arterial Spin Labeling (3D ASL) Market Size, Status and Forecast 2021-2027
QYR2104Z6125 2021年4月 96Pages
QYResearch社発行の本調査資料では、3D動脈スピンラベリング（3D ASL）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（キャッスル（CASL）、PASL）、用途別市場規模（腫瘍、脳血管障害、神経変性疾患、パーキンソン病）、主要地域別...

世界の皮膚糸状菌性爪真菌症治療（DOT）市場規模・現状・予測（2021年-2027年）

Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Size, Status and Forecast 2021-2027
QYR2104Z1805 2021年4月 98Pages
QYResearch社発行の本調査資料では、皮膚糸状菌性爪真菌症治療（DOT）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所、経口療法）、用途別市場規模（病院、皮膚科・足病クリニック、独立薬局、通信販売薬局、ドラッグストア）、主要地域別市...

世界のシリコン貫通電極（TSV）市場規模・現状・予測（2021年-2027年）

Global Through Silicon Via (TSV) Market Size, Status and Forecast 2021-2027
QYR2104Z5647 2021年4月 90Pages
QYResearch社発行の本調査資料では、シリコン貫通電極（TSV）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（2.5D TSV、3D TSV）、用途別市場規模（移動・家電、通信機器、自動車・輸送用電子機器、その他）、主要地域別市場規模（...

世界のハイスループットシーケンシング（HTS）市場規模・現状・予測（2021年-2027年）

Global High-Throughput Sequencing (HTS) Market Size, Status and Forecast 2021-2027
QYR2104Z2845 2021年4月 93Pages
QYResearch社発行の本調査資料では、ハイスループットシーケンシング（HTS）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（合成シーケンシング、連結シーケンシング）、用途別市場規模（腫瘍、遺伝性疾患検出、生命科学）、主要地域別市場規模（...

世界の軟骨無発生症市場 2021：企業別、地域別、種類・用途別 The Achondrogenesis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…
世界の髄膜炎診断検査市場規模・現状・予測（2021年-2027年） Inflammation to the meninges is known as meningitis. Most common cause of meningitis is bacteria or virus. Other causes include certain illness, medications or suffering from some other disease such as tuberculosis, or HIV (Human Immunodeficiency Virus). The testing for meningitis can be done using …
世界のECG・EEG検査市場規模・現状・予測（2021年-2027年） Electrocardiogram (ECG) is a test that tests the electrical activity of the heart and diagnoses abnormalities in cardiac functioning. Electroencephalography (EEG) is used to calculate the electrical activity of the brain. ECG and EEG devices tracked in this report are used to calculate parameters vi…
世界のアルツハイマー病診断市場規模・現状・予測（2021年-2027年） Alzheimer's disease (AD), also referred to simply asAlzheimer's, is a chronic neurodegenerative diseasethat usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss). …
世界のマラリア迅速診断検査（RDT）市場規模・現状・予測（2021年-2027年） Malaria rapid diagnostic tests (RDTs) assist in the diagnosis of malaria by detecting evidence of malaria parasites (antigens) in human blood. RDTs permit a reliable detection of malaria infections particularly in remote areas with limited access to good quality microscopy services. Market Analysis …